Addus Homecare Corp. diskutieren
Addus Homecare Corp.
WKN: A0YBKM / Symbol: ADUS / Name: Addus Homecare / Aktie / Anbieter & Dienstleistungen / Small Cap /
95,50 €
6,70 %
Addus HomeCare Co. (NASDAQ: ADUS) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for ADUS provided by MarketBeat
Addus HomeCare Co. (NASDAQ: ADUS) had its price target raised by analysts at Royal Bank of Canada from $121.00 to $123.00. They now have an "outperform" rating on the stock.
Ratings data for ADUS provided by MarketBeat
Addus HomeCare Co. (NASDAQ: ADUS) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $123.00 price target on the stock.
Ratings data for ADUS provided by MarketBeat
Addus HomeCare Co. (NASDAQ: ADUS) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for ADUS provided by MarketBeat
Addus HomeCare Co. (NASDAQ: ADUS) had its price target raised by analysts at Raymond James from $100.00 to $105.00. They now have an "outperform" rating on the stock.
Ratings data for ADUS provided by MarketBeat
Addus HomeCare Co. (NASDAQ: ADUS) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $118.00 price target on the stock.
Ratings data for ADUS provided by MarketBeat
Addus HomeCare Co. (NASDAQ: ADUS) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for ADUS provided by MarketBeat
Addus HomeCare Co. (NASDAQ: ADUS) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for ADUS provided by MarketBeat
Addus HomeCare Co. (NASDAQ: ADUS) had its price target lowered by analysts at Stephens from $110.00 to $105.00. They now have an "overweight" rating on the stock.
Ratings data for ADUS provided by MarketBeat
Addus HomeCare Co. (NASDAQ: ADUS) had its price target lowered by analysts at Royal Bank of Canada from $109.00 to $102.00. They now have an "outperform" rating on the stock.
Ratings data for ADUS provided by MarketBeat
Addus HomeCare Co. (NASDAQ: ADUS) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $118.00 price target on the stock.
Ratings data for ADUS provided by MarketBeat
Addus HomeCare Co. (NASDAQ: ADUS) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for ADUS provided by MarketBeat
Addus HomeCare Co. (NASDAQ: ADUS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $102.00 price target on the stock.
Ratings data for ADUS provided by MarketBeat
Addus HomeCare Co. (NASDAQ: ADUS) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $118.00 price target on the stock.
Ratings data for ADUS provided by MarketBeat
Addus HomeCare Co. (NASDAQ: ADUS) was downgraded by analysts at Barclays PLC from an "equal weight" rating to an "underweight" rating. They now have a $83.00 price target on the stock.
Ratings data for ADUS provided by MarketBeat
Addus HomeCare Co. (NASDAQ: ADUS) had its price target raised by analysts at Bank of America Co. from $115.00 to $118.00. They now have a "buy" rating on the stock.
Ratings data for ADUS provided by MarketBeat
Addus HomeCare Co. (NASDAQ: ADUS) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $115.00 price target on the stock.
Ratings data for ADUS provided by MarketBeat
Addus HomeCare Co. (NASDAQ: ADUS) had its price target raised by analysts at TD Cowen from $105.00 to $119.00. They now have a "buy" rating on the stock.
Ratings data for ADUS provided by MarketBeat
Neueste Beiträge
HC_Wainwright in Protagonist Therapeutics Inc diskutieren